What SEC filings does Teladoc Health, Inc. submit to the SEC?

Teladoc Health, Inc. (TDOC) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about TDOC?

A Form 4 for TDOC discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the source-reported date, number of shares, price, and updated ownership. These facts do not establish motive or predict future returns.

How do I interpret an 8-K filing from Teladoc Health, Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for TDOC?

The 10-K is Teladoc Health, Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all TDOC SEC filings directly on EDGAR?

You can view all historical Teladoc Health, Inc. filings on the SEC EDGAR company page for TDOC. Each filing card on this page links directly to the original SEC document.

How often does Teladoc Health, Inc. file with the SEC?

Teladoc Health, Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling TDOC shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

TDOC SEC Filing News — Teladoc Health, Inc.

Latest SEC filings for Teladoc Health, Inc. (TDOC) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-05.

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides …

Sector: Healthcare Industry: Health Information Services Market Cap: $1.0B CIK: 1477449

Total Filings

Bullish Classifications

Bearish Classifications

Insider Transactions

Material Events (8-K)

Periodic Reports

Rule-based classifications for TDOC currently lean bearish. Of the 20 filing records displayed, 8 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.

TDOC Filing Activity Snapshot 2026-08-04 — 2026-10-05

Insider Transactions (Form 4)

0 buys vs 8 sells

Net insider selling in this period — insiders sell for many reasons beyond conviction.

Largest Form 144 Filing

$115.5K

DIVITA CHARLES III (Director, CHIEF EXECUTIVE OFFICER) · 2026-09-03

18,327 shares · Form 4

Form 144 Notices

Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.

Insider Transactions 10 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 10 filings in this group are Form 4s for Teladoc Health, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 10 insider filings shown, the breakdown is 8 open-market sale and 2 compensation award. 8 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×8: The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Compensation award ×2: Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Form 4 Open-market sale Insider Selling 2026-10-05

TDOC insider Catapano Joseph Ronald (Chief Accounting Officer) sold 655 shares (~$3.7K)

Catapano Joseph Ronald, listed as Chief Accounting Officer at Teladoc Health, Inc., reported an open-market sale of 655 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	2,083	—	—
`S`	Open-market sale	655	$5.65	$3.7K
`M`	Option exercise derivative · Restricted Stock Units	2,083	—	—

Filing: Form 4 (Insider Transaction) Insider: Catapano Joseph Ronald (Chief Accounting Officer) Shares: 655 Est. Value: $3.7K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-14

TDOC insider DIVITA CHARLES III (Director, CHIEF EXECUTIVE OFFICER) sold 17,805 shares (~$108.7K)

DIVITA CHARLES III, listed as Director, CHIEF EXECUTIVE OFFICER at Teladoc Health, Inc., reported an open-market sale of 17,805 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	3,642	—	—
`M`	Option exercise	39,160	—	—
`S`	Open-market sale	17,805	$6.10	$108.7K
`M`	Option exercise derivative · Performance Stock Units	3,642	—	—
`M`	Option exercise derivative · Restricted Stock Units	39,160	—	—

Filing: Form 4 (Insider Transaction) Insider: DIVITA CHARLES III (Director, CHIEF EXECUTIVE OFFICER) Shares: 17,805 Est. Value: $108.7K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-03

TDOC insider Nueno Carlos (President, International) sold 6,200 shares (~$39.1K)

Nueno Carlos, listed as President, International at Teladoc Health, Inc., reported an open-market sale of 6,200 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	4,556	—	—
`M`	Option exercise	8,717	—	—
`S`	Open-market sale	6,200	$6.30	$39.1K
`M`	Option exercise derivative · Restricted Stock Units	4,556	—	—
`M`	Option exercise derivative · Restricted Stock Units	8,717	—	—

Filing: Form 4 (Insider Transaction) Insider: Nueno Carlos (President, International) Shares: 6,200 Est. Value: $39.1K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-03

TDOC insider Vandervoort Adam C (CHIEF LEGAL OFFICER, SECRETARY) sold 7,573 shares (~$47.7K)

Vandervoort Adam C, listed as CHIEF LEGAL OFFICER, SECRETARY at Teladoc Health, Inc., reported an open-market sale of 7,573 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	5,350	—	—
`M`	Option exercise	9,152	—	—
`M`	Option exercise	426	—	—
`S`	Open-market sale	7,573	$6.30	$47.7K
`M`	Option exercise derivative · Restricted Stock Units	5,350	—	—
`M`	Option exercise derivative · Restricted Stock Units	9,152	—	—
`M`	Option exercise derivative · Performance Stock Units	426	—	—

Filing: Form 4 (Insider Transaction) Insider: Vandervoort Adam C (CHIEF LEGAL OFFICER, SECRETARY) Shares: 7,573 Est. Value: $47.7K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-03

TDOC insider Bliss Kelly (President, U.S. Group Health) sold 7,357 shares (~$46.4K)

Bliss Kelly, listed as President, U.S. Group Health at Teladoc Health, Inc., reported an open-market sale of 7,357 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	4,859	—	—
`M`	Option exercise	9,152	—	—
`M`	Option exercise	1,300	—	—
`S`	Open-market sale	7,357	$6.30	$46.4K
`M`	Option exercise derivative · Restricted Stock Units	4,859	—	—
`M`	Option exercise derivative · Restricted Stock Units	9,152	—	—
`M`	Option exercise derivative · Performance Stock Units	1,300	—	—

Filing: Form 4 (Insider Transaction) Insider: Bliss Kelly (President, U.S. Group Health) Shares: 7,357 Est. Value: $46.4K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-03

TDOC insider Catapano Joseph Ronald (Chief Accounting Officer) sold 274 shares (~$1.7K)

Catapano Joseph Ronald, listed as Chief Accounting Officer at Teladoc Health, Inc., reported an open-market sale of 274 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	833	—	—
`M`	Option exercise	39	—	—
`S`	Open-market sale	274	$6.30	$1.7K
`M`	Option exercise derivative · Restricted Stock Units	833	—	—
`M`	Option exercise derivative · Performance Stock Units	39	—	—

Filing: Form 4 (Insider Transaction) Insider: Catapano Joseph Ronald (Chief Accounting Officer) Shares: 274 Est. Value: $1.7K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-03

TDOC insider DIVITA CHARLES III (Director, CHIEF EXECUTIVE OFFICER) sold 18,327 shares (~$115.5K)

DIVITA CHARLES III, listed as Director, CHIEF EXECUTIVE OFFICER at Teladoc Health, Inc., reported an open-market sale of 18,327 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	42,277	—	—
`M`	Option exercise	1,966	—	—
`S`	Open-market sale	18,327	$6.30	$115.5K
`M`	Option exercise derivative · Restricted Stock Units	42,277	—	—
`M`	Option exercise derivative · Performance Stock Units	1,966	—	—

Filing: Form 4 (Insider Transaction) Insider: DIVITA CHARLES III (Director, CHIEF EXECUTIVE OFFICER) Shares: 18,327 Est. Value: $115.5K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-09-03

TDOC insider Rodrigues Fernando M. (President of BetterHelp) sold 15,251 shares (~$98.1K)

Rodrigues Fernando M., listed as President of BetterHelp at Teladoc Health, Inc., reported an open-market sale of 15,251 TDOC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	5,492	—	—
`M`	Option exercise	1,042	—	—
`M`	Option exercise	8,717	—	—
`S`	Open-market sale	5,439	$6.30	$34.3K
`S`	Open-market sale	9,812	$6.51	$63.9K
`M`	Option exercise derivative · Restricted Stock Units	5,492	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,042	—	—
`M`	Option exercise derivative · Restricted Stock Units	8,717	—	—

Filing: Form 4 (Insider Transaction) Insider: Rodrigues Fernando M. (President of BetterHelp) Shares: 15,251 Est. Value: $98.1K

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-09-01

TDOC insider Form 4 filed for equity award, exercise, or tax withholding

Grasher Michael F (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award derivative · Restricted Stock Units	239,616	—	—

Filing: Form 4 (Insider Transaction) Insider: Grasher Michael F (Chief Financial Officer)

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-08-04

TDOC insider Form 4 filed for equity award, exercise, or tax withholding

Anquillare Mark V (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award derivative · Restricted Stock Units	37,425	—	—

Filing: Form 4 (Insider Transaction) Insider: Anquillare Mark V (Director)

View on SEC EDGAR → Open Filing Document →

Proposed Insider Sales 7 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Teladoc Health, Inc. has 7 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-11

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-09-03

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-09-02

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-09-02

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-09-02

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-09-02

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-09-02

TDOC Form 144 filed for proposed insider sale

An insider at Teladoc Health, Inc. filed a Form 144 notifying the SEC of an intent to sell shares. Form 144 is a proposed sale notice rather than confirmation that a sale already happened.

Filing: Form 144 (Proposed Sale Notice)

View on SEC EDGAR → Open Filing Document →

Material Events 3 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 3 in this period for Teladoc Health, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-25

TDOC filed 8-K — material company event

Teladoc Health, Inc. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-08-31

TDOC filed 8-K — material company event

Teladoc Health, Inc. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-08-13

TDOC filed 8-K — material company event

Teladoc Health, Inc. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

How we classify Teladoc Health, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on TDOC. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — TDOC SEC Filings

More Tools for TDOC

TDOC Full Stock Analysis TDOC Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper TDOC analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the TDOC stock analysis page.

TDOC Full Analysis

Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.

Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer